This is perhaps due to the fact that when the TCR2C transgenic mice were crossed with the Tpl2−/−, the transgenic CD8+ T cells were transformed into chronically stimulated T cells and developed into lymphomas, which led the authors to conclude that Tpl2 may be playing an anti-proliferative role in murine CTLs [29]. The gene discussed is CD8A; the disease is lymphoma.